Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
304
-
Total 13F shares, excl. options
-
73.7M
-
Shares change
-
-7.34M
-
Total reported value, excl. options
-
$3.25B
-
Value change
-
-$236M
-
Put/Call ratio
-
0.43
-
Number of buys
-
193
-
Number of sells
-
-108
-
Price
-
$44.13
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q1 2025
374 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 304 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.7M shares
of 75.6M outstanding shares and own 97.47% of the company stock.
Largest 10 shareholders include FMR LLC (11.2M shares), VANGUARD GROUP INC (7.08M shares), BlackRock, Inc. (6.25M shares), STATE STREET CORP (2.92M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.58M shares), Woodline Partners LP (2.14M shares), Polar Capital Holdings Plc (1.75M shares), GEODE CAPITAL MANAGEMENT, LLC (1.72M shares), Pictet Asset Management Holding SA (1.67M shares), and D. E. Shaw & Co., Inc. (1.66M shares).
This table shows the top 304 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.